Cardax, Inc. (CDXI)
Makes anti-inflammatory supplements and drugs from natural pigments.
$0.00+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+0.0%
The outlook
CDXI is trading at a penny stock level with minimal daily movement. The price sits well above its longer-term moving averages, though it remains near the bottom of its 52-week range. Analyst coverage appears limited, and the overall sentiment registers as neutral.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range2% of the way from its 52-week low to high
Market cap
$80
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—